Oncology Institute, Inc. (NASDAQ:TOI) showed up in the 13F filings of 115 institutional investors as of March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 4,415,867 | 510,534 | 13.07% | $13,556,712.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 3,476,781 | 3,476,781 | 0.00% | $10,673,718.00 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 31 Mar, 2026 | 3,360,052 | 0 | 0.00% | $10,315,360.00 |
| Kanen Wealth Management LLC | 31 Mar, 2026 | 2,777,858 | -198,286 | -6.66% | $8,528,024.00 |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 31 Mar, 2026 | 2,464,359 | 4,550 | 0.18% | $7,565,582.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Mar, 2026 | 1,826,370 | -692,067 | -27.48% | $5,606,956.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,757,847 | 187,393 | 11.93% | $5,397,829.00 |
| WEXFORD CAPITAL LP | 31 Mar, 2026 | 1,711,323 | 177,867 | 11.60% | $5,253,762.00 |
| CenterBook Partners LP | 31 Mar, 2026 | 1,568,423 | -1,460,889 | -48.23% | $4,815,059.00 |
| State Street Corp | 31 Mar, 2026 | 1,461,454 | 109,830 | 8.13% | $4,486,664.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 1,351,899 | 211,051 | 18.50% | $4,150,330.00 |
| BRC Group Holdings, Inc. | 31 Mar, 2026 | 929,734 | 266,358 | 40.15% | $2,854,283.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 902,809 | 180,909 | 25.06% | $2,771,624.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 862,839 | 862,839 | 0.00% | $2,648,916.00 |
| Ensign Peak Advisors, Inc | 31 Mar, 2026 | 626,852 | 626,852 | 0.00% | $1,924,436.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 608,267 | 608,267 | 0.00% | $1,867,380.00 |
| UBS Group AG | 31 Mar, 2026 | 574,652 | 286,966 | 99.75% | $1,764,182.00 |
| Northern Trust Corp | 31 Mar, 2026 | 558,455 | 59,211 | 11.86% | $1,714,457.00 |
| FourWorld Capital Management LLC | 31 Mar, 2026 | 499,196 | 116,496 | 30.44% | $1,532,532.00 |
| VANGUARD FIDUCIARY TRUST CO | 31 Mar, 2026 | 483,060 | 483,060 | 0.00% | $1,482,994.00 |